시장보고서
상품코드
1514978

세계의 바이러스 검사 시장 : 유형별, 진단별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

Virology Testing Market, By Type, By Diagnosis, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 266 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

바이러스 검사 시장 규모는 2023년 129억 10만 달러로 2024-2032년에 걸쳐 CAGR 2.90%로 확대

바이러스 검사 시장 - 시장 역학

바이러스 감염의 만연과 개인화 의약품 증가가 시장 수요를 촉진할 전망

바이러스성 질환의 빈발과 확산은 바이러스 검사 수요를 촉진합니다. 인플루엔자, HIV, 간염, 지카 및 에볼라 출혈열과 같은 신흥 바이러스와 같은 질병의 발생은 시장 성장에 기여합니다. 바이러스성 질환에 대한 의식의 높아짐과 조기 발견·진단의 중요성이, 스크리닝 검사를 받는 것을 장려하고 있습니다. 공중 보건 활동, 예방 접종 캠페인 및 정기적 인 스크리닝 프로그램도 시장 수요를 촉진합니다. 포인트 오브 케어 검사, PCR, 차세대 시퀀싱과 같은 최신 바이러스 검사 방법은 감도, 특이성 및 진단 속도를 향상시킵니다. 시장 확대는 데이터 분석, 자동화 및 분석 개발의 지속적인 혁신으로 더욱 촉진됩니다.

바이러스 학적 검사와 같은 분자진단의 필요성은 독자적인 바이러스 및 유전자 프로파일을 기반으로 치료법을 사용자 정의하는 것을 목표로하는 맞춤형 의료 및 프리시전 의료의 동향에 밀려 있습니다. COVID-19 팬데믹과 같은 사건에서 입증된 바와 같이, 강력한 바이러스학적 검사 인프라는 새로운 감염의 조기 진단, 모니터링 및 봉쇄에 필수적입니다. 유행에 대한 대비와 대응을 개선하기 위해 정부와 의료 기관은 바이러스 학적 검사 능력에 대한 투자에 높은 우선 순위를두고 있습니다.

바이러스 검사 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 2.90%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측됩니다.

유형별로 장비 부문은 소형 장비 및 관련 키트에 대한 높은 수요로 인해 2023년에 가장 큰 시장 점유율을 보여줄 것으로 예측됩니다.

진단별로는 PCR법이 바이러스나 병원체의 검출에 널리 사용되고 있기 때문에 2023년에는 PCR법 부문이 주요 진단 부문이 되었습니다.

최종 사용자별로는 병원 및 클리닉 부문이 2023년 주요 최종 사용자였습니다.

지역별로 북미가 의료산업에 대한 지출이 많기 때문에 2023년에 수익을 가져오는 주요 시장이었습니다.

바이러스 검사 시장 - 세분화 분석 :

세계의 바이러스 검사 시장은 유형, 진단, 최종 사용자, 지역에 따라 구분됩니다.

유형별로는 장비, 분석 키트, 소모품의 세 가지로 분류됩니다. 장비 부문이 시장을 독점하고 있습니다. 기기를 이용한 항원 검사나 바이러스 검사에 대한 높은 수요가 시장의 성장을 가속하고 있습니다.

시장은 진단법에 의해 5가지 카테고리로 분류됩니다, PCR법, 분자진단법, 질량분석법, 면역측정법, 기타. 시장을 독점하고 있는 것은 PCR법입니다. 최근 COVID-19 팬데믹병 및 호흡기 질환은 PCR 방법 부문에 대한 수요를 높이고 있습니다.

시장은 최종 사용자별로 병원 및 클리닉, 진단실, 기타 3가지로 분류됩니다. 병원 및 클리닉 부문은 시장을 독점하고 있으며 예측 기간 동안에도 높은 우위를 유지할 것으로 예측됩니다. 진단 실험실 부문은 기술이 발전함에 따라 예측 기간 동안 가장 높은 성장률로 확대될 것으로 예측됩니다.

바이러스 검사 시장 - 지리적 통찰

바이러스 검사 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 퍼져 있습니다. 북미는 세계 시장을 독점하고 있습니다. 미국은 높은 의료 지출, 고급 의료 인프라, 강력한 R&D 능력 등의 요인으로 바이러스 검사 시장을 독점하고 있습니다. 아시아태평양은 의료비 증가, 바이러스성 질병 유행 증가, 의료서비스 접근성 개선 등의 요인으로 바이러스 검사 시장에 큰 성장 기회를 제공합니다. 주요 개발에는 진단 검사 시설의 확대와 신속 검사 기술의 채용 등이 있습니다.

바이러스 검사 시장 - 경쟁 구도:

바이러스 검사 시장에는 다국적 기업과 국내 기업, 제네릭 의약품 제조업체, 기술 의약품 개발 기업이 혼재하고 있습니다. 시장의 주요 진출기업은 파트너십 형성, M&A, R&D에 투자하고 새로운 검사 기술을 혁신하기 위해 노력하고 있습니다. 예를 들어 Abbot은 HIV, 간염, 인플루엔자와 같은 바이러스에 대한 분자 및 항원 기반 검사를 개발하고 있습니다. Abbot은 또한 Bill & Melinda Gates Foundation과 같은 조직과 파트너십을 맺고 제한된 자원 환경에서 HIV 검사에 대한 접근을 확대하고 있습니다.

목차

제1장 바이러스 검사 시장 개요

  • 조사 범위
  • 시장 추정년

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 바이러스 검사의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 바이러스 검사 업계의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 틀 분석

제5장 바이러스 검사 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 바이러스 검사 시장 상황

  • 바이러스 검사 시장 점유율 분석, 2024년
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 바이러스 검사 시장-유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 기기
    • 분석 키트
    • 소모품

제8장 바이러스 검사 시장-진단별

  • 개요
    • 진단별 부문 점유율 분석
    • 분자진단법
    • PCR법
    • 면역 측정법
    • 질량 분석법
    • 기타

제9장 바이러스 검사 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원 및 클리닉
    • 진단 실험실
    • 기타

제10장 바이러스 검사 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 바이러스 검사 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Abbott Laboratories
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories
    • Cepheid
    • Hologic, Inc.
    • Quidel Corporation
    • Siemens Healthineers
    • BD
    • bioMerieux
    • Qiagen
    • Meridian Bioscience, Inc.
    • Luminex Corporation
    • DiaSorin
    • Anitoa
    • 기타

제12장 애널리스트의 전방위 전망

JHS 24.07.26

REPORT HIGHLIGHT

Virology Testing Market size was valued at USD 12,900.10 Million in 2023, expanding at a CAGR of 2.90% from 2024 to 2032.

Virology testing refers to a range of laboratory tests used to detect the presence of viruses or viral components in biological samples such as blood, saliva, or tissue. These tests are crucial for diagnosing viral infections, monitoring disease progression, and assessing the effectiveness of Diagnosis.

Virology Testing Market- Market Dynamics

Growing prevalence of viral infections and personalized medicines are expected to propel market demand

The frequency and spread of viral diseases drive the demand for virology testing. Outbreaks of diseases like influenza, HIV, hepatitis, and emerging viruses like Zika and Ebola contribute to the market growth. Growing awareness about viral diseases and the importance of early detection and Diagnosis encourages individuals to undergo screening tests. Public health initiatives, vaccination campaigns, and routine screening programs also fuel market demand. Modern virology testing methods, like point-of-care testing, PCR, and next-generation sequencing, improve sensitivity, specificity, and speed of diagnosis. Market expansion is further fueled by ongoing innovation in data analysis, automation, and assay development.

The need for molecular diagnostics, such as virology testing, is driven by the trend toward personalized medicine and precision healthcare, which aims to customize therapies based on unique viral and genetic profiles. A strong virology testing infrastructure is essential for the early diagnosis, surveillance, and containment of new infectious diseases, as demonstrated by events like the COVID-19 pandemic. To improve pandemic preparedness and response, governments and healthcare institutions place a high priority on investing in virology testing capabilities.

Virology Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.90% over the forecast period (2024-2032)

Based on Type segmentation, the instruments segment was predicted to show maximum market share in the year 2023, owing to its high demand for small instruments & related kits.

Based on Diagnosis segmentation, the PCR-based method segment was the leading Diagnosis in 2023, PCR methods are widely used for detecting viruses & pathogens.

Based on End User segmentation, the hospitals & clinics segment was the leading End User in 2023, owing to the high demand for virology testing at hospitals & clinics.

On the basis of region, North America was the leading revenue generator in 2023, owing to high spending on the healthcare industry.

Virology Testing Market- Segmentation Analysis:

The Global Virology Testing Market is segmented on the basis of Type, Diagnosis, End User, and Region.

The market is divided into three categories based on Type: instruments, assay kits, and consumables. The instruments segment dominates the market. High demands for antigen and viruses tests using instruments is promoting market growth.

The market is divided into five categories based on the diagnosis: PCR-based method, molecular diagnostics method, mass spectroscopy-based method, immunoassay-based method, and others. The PCR-based method segment dominates the market. The recent COVID-19 pandemic and respiratory diseases are increasing the need for PCR-based method segment demand.

The market is divided into three categories based on End Users: hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The diagnostic laboratories segment is expected to expand at the highest rate over the forecast period with advancement in technologies.

Virology Testing Market- Geographical Insights

Worldwide, the Virology Testing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global market. The United States dominates the virology testing landscape due to factors such as high healthcare expenditure, advanced healthcare infrastructure, and strong R&D capabilities. The Asia-Pacific region presents significant growth opportunities for the virology testing market, fueled by factors such as rising healthcare expenditure, increasing prevalence of viral diseases, and improving access to healthcare services. Key developments include the expansion of diagnostic testing facilities and adoption of rapid testing technologies.

Virology Testing Market- Competitive Landscape:

The virology testing market includes a mix of multinational and domestic firms, generic drug manufacturers, and technology drug development companies. Major players in the market engage in forming partnerships, mergers and acquisitions, and investing in research and development to innovate new testing technologies. For example, Abbott has developed molecular and antigen-based tests for viruses such as HIV, hepatitis, and influenza. Abbott has also entered partnerships with organizations like the Bill & Melinda Gates Foundation to expand access to HIV testing in resource-limited settings.

Recent Developments:

In June 2022, Anitoa, a United States startup company developed a portable PCR molecular assay for monkeypox virus detection.

In 2022, Quidel Corporation a provider of rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic announces antigen testing solutions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIROLOGY TESTING MARKET KEY PLAYERS

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Cepheid
  • Hologic, Inc.
  • Quidel Corporation
  • Siemens Healthineers
  • BD
  • bioMerieux
  • Qiagen
  • Meridian Bioscience, Inc.
  • Luminex Corporation
  • DiaSorin
  • Anitoa
  • Others

GLOBAL VIROLOGY TESTING MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Instruments
  • Assay Kits
  • Consumables

GLOBAL VIROLOGY TESTING MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019-2032

  • Molecular Diagnostics Method
  • PCR-based method
  • Immunoassay-based method
  • Mass spectroscopy-based method
  • Others

GLOBAL VIROLOGY TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals & clinics
  • Diagnostic laboratories
  • Others

GLOBAL VIROLOGY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Virology Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Virology Testing Market Snippet by Type
    • 2.1.2. Virology Testing Market Snippet by Diagnosis
    • 2.1.3. Virology Testing Market Snippet by End User
    • 2.1.4. Virology Testing Market Snippet by Country
    • 2.1.5. Virology Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Virology Testing Key Market Trends

  • 3.1. Virology Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Virology Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Virology Testing Market Opportunities
  • 3.4. Virology Testing Market Future Trends

4. Virology Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Virology Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Virology Testing Market Landscape

  • 6.1. Virology Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Virology Testing Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Assay Kits
    • 7.1.4. Consumables

8. Virology Testing Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2024 & 2032 (%)
    • 8.1.2. Molecular Diagnostics Method
    • 8.1.3. PCR-based method
    • 8.1.4. Immunoassay-based method
    • 8.1.5. Mass spectroscopy-based method
    • 8.1.6. Others

9. Virology Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & clinics
    • 9.1.3. Diagnostic laboratories
    • 9.1.4. Others

10. Virology Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Virology Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Virology Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Virology Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Virology Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Virology Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Virology Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Thermo Fisher Scientific
    • 11.2.4. Bio-Rad Laboratories
    • 11.2.5. Cepheid
    • 11.2.6. Hologic, Inc.
    • 11.2.7. Quidel Corporation
    • 11.2.8. Siemens Healthineers
    • 11.2.9. BD
    • 11.2.10. bioMerieux
    • 11.2.11. Qiagen
    • 11.2.12. Meridian Bioscience, Inc.
    • 11.2.13. Luminex Corporation
    • 11.2.14. DiaSorin
    • 11.2.15. Anitoa
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제